Alzamend Neuro's total assets for Q1 2026 were $6.33M, an increase of 51.52% from the previous quarter. ALZN total liabilities were $983.31K for the fiscal quarter, a 35.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.